Beshay V - Search Results

1

Patients with multiple myeloma treated with thalidomide: evaluation of clinical parameters, cytokines,angiogenic markers, mast cells and marrow CD57+ cytotoxic T cells as predictors of outcome.

Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, Beshay V, Ritchie D, Simmons P, Milner AD, Zeldis JB, Prince HM. Mileshkin L, et al. Among authors: beshay v. Haematologica. 2007 Aug;92(8):1075-82. doi: 10.3324/haematol.11208. Epub 2007 Jul 20. Haematologica. 2007. PMID: 17640854 Free article.

2

KIT immunohistochemistry and mutation status in gastrointestinal stromal tumours (GISTs) evaluated for treatment with imatinib.

Loughrey MB, Trivett M, Beshay V, Dobrovic A, Kovalenko S, Murray W, Lade S, Turner H, McArthur GA, Zalcberg J, Waring PM. Loughrey MB, et al. Among authors: beshay v. Histopathology. 2006 Jul;49(1):52-65. doi: 10.1111/j.1365-2559.2006.02464.x. Histopathology. 2006. PMID: 16842246

3

Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Loughrey MB, Waring PM, Tan A, Trivett M, Kovalenko S, Beshay V, Young MA, McArthur G, Boussioutas A, Dobrovic A. Loughrey MB, et al. Among authors: beshay v. Fam Cancer. 2007;6(3):301-10. doi: 10.1007/s10689-007-9124-1. Epub 2007 Apr 24. Fam Cancer. 2007. PMID: 17453358

4

Monogenic and polygenic determinants of sarcoma risk: an international genetic study.

Ballinger ML, Goode DL, Ray-Coquard I, James PA, Mitchell G, Niedermayr E, Puri A, Schiffman JD, Dite GS, Cipponi A, Maki RG, Brohl AS, Myklebost O, Stratford EW, Lorenz S, Ahn SM, Ahn JH, Kim JE, Shanley S, Beshay V, Randall RL, Judson I, Seddon B, Campbell IG, Young MA, Sarin R, Blay JY, O'Donoghue SI, Thomas DM; International Sarcoma Kindred Study. Ballinger ML, et al. Among authors: beshay v. Lancet Oncol. 2016 Sep;17(9):1261-71. doi: 10.1016/S1470-2045(16)30147-4. Epub 2016 Aug 4. Lancet Oncol. 2016. PMID: 27498913

5

Cerebral relapse of metastatic gastrointestinal stromal tumor during treatment with imatinib mesylate: case report.

Hughes B, Yip D, Goldstein D, Waring P, Beshay V, Chong G. Hughes B, et al. Among authors: beshay v. BMC Cancer. 2004 Oct 9;4:74. doi: 10.1186/1471-2407-4-74. BMC Cancer. 2004. PMID: 15473910 Free PMC article.

6

Resistance to imatinib, low-grade FDG-avidity on PET, and acquired KIT exon 17 mutation in gastrointestinal stromal tumour.

Grimpen F, Yip D, McArthur G, Waring P, Goldstein D, Loughrey M, Beshay V, Chong G. Grimpen F, et al. Among authors: beshay v. Lancet Oncol. 2005 Sep;6(9):724-7. doi: 10.1016/S1470-2045(05)70321-1. Lancet Oncol. 2005. PMID: 16129374 No abstract available.

7

Pathological response of gastrointestinal stromal tumour to imatinib treatment correlates with tumour KIT mutational status in individual tumour clones.

Loughrey MB, Beshay V, Dobrovic A, Zalcberg J, Waring PM. Loughrey MB, et al. Among authors: beshay v. Histopathology. 2006 Jul;49(1):99-100. doi: 10.1111/j.1365-2559.2006.02336.x. Histopathology. 2006. PMID: 16842259 No abstract available.

8

A high-throughput protocol for mutation scanning of the BRCA1 and BRCA2 genes.

Hondow HL, Fox SB, Mitchell G, Scott RJ, Beshay V, Wong SQ; kConFab Investigators; Dobrovic A. Hondow HL, et al. Among authors: beshay v. BMC Cancer. 2011 Jun 24;11:265. doi: 10.1186/1471-2407-11-265. BMC Cancer. 2011. PMID: 21702907 Free PMC article.

9

Large genomic rearrangements in the familial breast and ovarian cancer gene BRCA1 are associated with an increased frequency of high risk features.

James PA, Sawyer S, Boyle S, Young MA, Kovalenko S, Doherty R, McKinley J, Alsop K, Beshay V, Harris M, Fox S, Lindeman GJ, Mitchell G. James PA, et al. Among authors: beshay v. Fam Cancer. 2015 Jun;14(2):287-95. doi: 10.1007/s10689-015-9785-0. Fam Cancer. 2015. PMID: 25678442

10

Report of a bi-allelic truncating germline mutation in TP53.

Brown NJ, Bhatia K, Teague J, White SM, Lo P, Challis J, Beshay V, Sullivan M, Malkin D, Hansford JR. Brown NJ, et al. Among authors: beshay v. Fam Cancer. 2019 Jan;18(1):101-104. doi: 10.1007/s10689-018-0087-1. Fam Cancer. 2019. PMID: 29737433

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters